Newly discovered dermoscopy features differentiate melanoma in situ from benign lesions, shows a study in JAMA Dermatology.
Researchers suggest that an assessment of cardiovascular risk factors in the atopic dermatitis patient population is prudent.
The decrease in the diversity of skin microbiome in megacities may contribute to a higher incidence of skin diseases in more urbanized environments, researchers report.
Now, scientists know how one gene mutation leads to skin cancer — as well as other epithelial cancers such as lung, esophagus, mouth and throat. This groundbreaking discovering may lead to the development of new treatments and clinical trials.
Adults with moderate to severe atopic dermatitis with comorbid asthma experience the same improvement in disease signs and symptoms with dupilumab treatment as those without asthma, according to pooled data from two large phase three clinical trials.
Eczema, food allergy, and asthma independently and cumulatively increase the risk for eosinophilic esophagitis (EoE), according to findings presented at the 2018 American Academy of Allergy, Asthma & Immunology and World Allergy Organization Joint Congress in Orlando.
A strain of Staphylococcus epidermidis, a common microbe on healthy human skin, produces a chemical compound that has the ability to impair growth of skin neoplasia, researchers have found.
Alterations in lipid metabolism can be detrimental to skin barrier function leading to atopic dermatitis, researchers have found.
The transcription factor "retinoid-related orphan receptor-alpha" (RORA) has been identified as a regulator of T regulatory (Treg) genes responsible for suppressing allergic skin inflammation, researchers report.
Dupilumab given concomitantly with topical corticosteroids significantly improved signs and symptoms of atopic dermatitis (AD) in adults refractory to or intolerant of cyclosporine A, a study shows.